Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-01 @ 8:12 AM
Study NCT ID:
NCT01777256
Status:
TERMINATED
Last Update Posted:
2017-04-26
First Post:
2013-01-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03-01
Start Date Type:
None
Primary Completion Date:
2014-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-24
First Submit QC Date:
None
Study First Post Date:
2013-01-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-25
Last Update Post Date:
2017-04-26
Last Update Post Date Type:
ACTUAL